4.89
0.08 (1.66%)
| 前收盘价格 | 4.81 |
| 成交量 | 92,860 |
| 平均成交量 (3个月) | 45,214 |
| 市值 | 62,016,060 |
| 市盈率 (P/E TTM) | 23.29 |
| 价格/销量 (P/S) | 0.350 |
| 股市价格/股市净资产 (P/B) | 1.82 |
| 52周波幅 | |
| 利润日期 | 4 Feb 2027 |
| 股息率 (DY TTM) | 3.89% |
| 营业毛利率 | 1.58% |
| 营业利益率 (TTM) | 2.50% |
| 稀释每股收益 (EPS TTM) | 0.210 |
| 季度收入增长率 (YOY) | -22.00% |
| 季度盈利增长率 (YOY) | 109.20% |
| 总债务/股东权益 (D/E MRQ) | 28.28% |
| 流动比率 (MRQ) | 1.91 |
| 营业现金流 (OCF TTM) | 13.08 M |
| 杠杆自由现金流 (LFCF TTM) | 13.40 M |
| 资产报酬率 (ROA TTM) | 4.45% |
| 股东权益报酬率 (ROE TTM) | 8.19% |
AIStockmoo 评分
| 价值 30% | 0.3 |
| 当前股价隐含每年 13.5% 的盈利增长;公司业务可支撑约每年 1.3% 的增长。 参考 | |
| 低于其一贯估值。 参考 | |
| 资本回报远高于资本成本。资本回报上升。 参考 | |
| 负债低。短期流动性充足。现金流为正。 参考 | |
| 来自我们的 AI Insight 报告对预期回报与风险的评估。 参考 | NA |
| 相对估值 参考 | NA |
| 持仓估值 参考 | NA |
| 风险溢价 参考 | NA |
| 市场估值 参考 | NA |
| 时机 30% | -3.5 |
| 过去一年没有明确趋势。股价远低于52周高点。 参考 | |
| 下降趋势:股价位于均线之下,均线向下。股价接近均线。上涨日成交量较大。 参考 | |
| 来自我们对走势图的 AI 技术分析。 参考 | NA |
| K线形态 参考 | NA |
| 市场情绪 20% | -0.3 |
| 近期没有目标价,因此依据目标价的调整方向。 参考 | |
| 近期新闻好坏参半或中性。 参考 | |
| 持仓情绪 参考 | NA |
| 聪明钱 20% | -1.4 |
| 内部人士近期净卖出。 参考 | |
| 机构在最新13F申报中净-2.90%的股份:31家增持,52家减持(截至30 Sep 2026的季度)。 参考 | |
| 空头持仓从31 Aug到30 Oct 2026变化-25.8%,回补天数42.1天(FINRA)。 参考 | |
| 市场和行业状况不佳。 | |
| 市场环境偏谨慎。 参考 | |
| 行业表现落后大市。 | |
| 各支柱方向一致,评分因此加强。 | |
| 不计入评分 | |
| 每股盈利有升有降。 参考 | |
| 低于中期趋势线。 参考 | |
| 股价低于其52周平均水平。5年来下跌。 参考 | |
| 短、中、长期趋势均向下。短期动能下降。 参考 | |
| 股价接近支撑位。支撑与阻力水平趋升。 参考 | |
| 最终评分 | -1.67 |
市场趋势
| 短期 | 中期 | ||
| 行业 | Packaged Foods (US) | 混合的 | 看跌 |
| Packaged Foods (全球的) | 看跌 | 看跌 | |
| 股票 | Lifevantage Corporation | 混合的 | 混合的 |
相关股票
| 股票 | 市值 | DY | P/E(TTM) | P/B | 评分 |
|---|---|---|---|---|---|
| LFVN | 62 M | 3.89% | 23.29 | 1.82 | -1.7 |
| CPB | 7 B | 5.97% | 18.15 | 1.89 | -0.2 |
| PPC | 7 B | - | 21.34 | 1.70 | 0.0 |
| CENT | 3 B | - | 16.94 | 1.70 | 0.6 |
| SENEB | 1 B | - | 10.12 | 1.52 | 0.2 |
| WEST | 723 M | - | - | - | -0.4 |
|
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands. |
|
| 部门 | Consumer Defensive |
| 行业 | Packaged Foods |
| 投资方式 | Small Value |
| 内部持股比例 | 14.30% |
| 机构持股比例 | 52.25% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Advyzon Investment Management, Llc | 30 Sep 2026 | 100,678 |
| Indivisible Partners | 30 Sep 2026 | 98,842 |
该时间范围内无数据。
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| BEINDORFF MICHAEL A | - | 5.04 | -10,000 | -50,400 |
| 累积净数量 | -10,000 | |||
| 累积净值 ($) | -50,400 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 5.04 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| BEINDORFF MICHAEL A | 董事 | 12 Nov 2026 | 卖 (-) | 10,000 | 5.04 | 50,400 |
机构
机构持股比例: 50.50%
| 持仓变动 | 机构数 | 股数 |
|---|---|---|
| 增持 | 31 | 734,211 |
| 减持 | 52 | 866,403 |
| 新建仓 | 10 | 42,789 |
| 清仓 | 18 | 287,341 |
来源:经Nasdaq的SEC 13F申报,最新申报截至30 Sep 2026。申报在每季结束后45天内陆续提交。
空头持仓
| 结算日 | 股数 | 回补天数 |
|---|---|---|
| 30 Oct 2026 | 906,622 | 42.1 |
| 15 Oct 2026 | 976,051 | 28.8 |
| 30 Sep 2026 | 1,068,085 | 32.6 |
| 15 Sep 2026 | 1,137,906 | 23.6 |
| 31 Aug 2026 | 1,221,521 | 22.2 |
| 14 Aug 2026 | 1,207,968 | 21.2 |
来源:经Nasdaq的FINRA空头持仓数据,每月公布两次。
| 日期 | 类型 | 细节 |
|---|---|---|
| 10 Nov 2026 | Yahoo Finance |
Lifevantage Corp (LFVN) (Q1 2027) Earnings Call Highlights: Revenue Slides 22% as Strategic ...
Lifevantage Corp (LFVN) posted a $37.1 million quarterly revenue decline but preserved a debt-free balance sheet while investing in a digital overhaul and brand repositioning. |
| 09 Nov 2026 | Yahoo Finance |
LifeVantage Corporation Q1 2027 Earnings Call Summary
Moby summary of LifeVantage Corporation's Q1 2027 earnings call… |
| 09 Nov 2026 | Yahoo Finance |
LifeVantage (LFVN) Q1 2027 Earnings Call Transcript
Sales slid 22% as management overhauls strategy and shifts its fiscal calendar. |
| 09 Nov 2026 | Yahoo Finance |
What Lifevantage (LFVN) Said on Its Q1 Earnings Call
Lifevantage (NASDAQ:LFVN) reported a 22% decline in revenue for its fiscal first quarter and outlined a strategy to overhaul its brand, digital sales tools and cost structure as it works to stabilize the business. Revenue for the quarter ended September 30, 2026, fell to $37.1 million from $47.6 mi… |
| 09 Nov 2026 | Yahoo Finance |
Lifevantage (LFVN) Surpasses Q1 Earnings Estimates
Lifevantage (LFVN) delivered earnings and revenue surprises of +66.67% and -3.84%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock? |
| 09 Nov 2026 | Yahoo Finance |
Lifevantage: Fiscal Q1 Earnings Snapshot
LEHI, Utah (AP) — LEHI, Utah (AP) — Lifevantage Corp. (LFVN) on Monday reported a loss of $196,000 in its fiscal first quarter. |
| 09 Nov 2026 | Yahoo Finance |
LifeVantage Declares Quarterly Dividend
SALT LAKE CITY, Nov. 09, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash… |
| 09 Nov 2026 | Yahoo Finance |
LifeVantage Announces Financial Results for the First Quarter Fiscal 2027
SALT LAKE CITY, Nov. 09, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its quarter ended September 30, 2026. First Quarter… |
| 29 Oct 2026 | Yahoo Finance |
Pro-Dex, Inc. (PDEX) Q1 Earnings and Revenues Surpass Estimates
ProDex (PDEX) delivered earnings and revenue surprises of +37.31% and +0.78%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock? |
| 29 Oct 2026 | Yahoo Finance |
New LifeVantage Research Explores How Protandim® Nrf2 Supports Cellular Defense Against Five Modern Environmental Toxins*
SALT LAKE CITY, Oct. 29, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN) continues to lead the next generation of healthy aging with its latest in vitro research study examining how five modern environmental toxins—pollution, microplastics, ultra-processed foods, hormone… |
| 26 Oct 2026 | Yahoo Finance |
LifeVantage to Announce First Quarter Fiscal Year 2027 Results on November 9, 2026
SALT LAKE CITY, Oct. 26, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its first quarter ended… |
| 19 Oct 2026 | Yahoo Finance |
New Strong Sell Stocks for October 19th
CWH, LFVN and CGAU have been added to the Zacks Rank #5 (Strong Sell) List on October 19, 2026… |
| 12 Oct 2026 | Yahoo Finance |
LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SALT LAKE CITY, Oct. 12, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”) today announced that its Board of Directors granted inducement awards to Terrence Moorehead, the Company’s President and Chief Executive Officer, under the Company’s 2026 New… |
| 24 Sep 2026 | Yahoo Finance |
LifeVantage Unveils Turnaround Plan to Rebuild Brand, Margins and Growth
Lifevantage (NASDAQ:LFVN) executives outlined a turnaround plan centered on strengthening the company’s brand, improving consumer relevance and increasing operating efficiency during a Water Tower Research conference discussion. President and CEO Terrence Moorehead, who recently joined the company,… |
| 18 Sep 2026 | Yahoo Finance |
LifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026
SALT LAKE CITY, Sept. 18, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Terrence Moorehead, Chief Executive Officer, and Carl Aure, Chief… |
| 31 Aug 2026 | Yahoo Finance |
LifeVantage (LFVN) Q4 2026 Earnings Call Transcript
Revenue fell 23% as macroeconomic pressures weighed on orders and average order sizes. |
| 28 Aug 2026 | Yahoo Finance |
LifeVantage Corporation Q4 2026 Earnings Call Summary
Moby summary of LifeVantage Corporation's Q4 2026 earnings call… |
| 28 Aug 2026 | Yahoo Finance |
Lifevantage Corp (LFVN) (Q4 2026) Earnings Call Highlights: Revenue Declines 23% Amid Strategic ...
New CEO outlines turnaround plan as subscription base remains resilient despite macroeconomic headwinds… |
| 显示更多 | ||
| 股息率 (DY TTM) | 3.89% |
| 4年平均股息收益率 | 3.77% |
| 股息支付比率 | 90.48% |
| 预计下次股息支付 | Mar 2027 |
| 除息日 | 公告日期 | 支付日期 | 详情 |
|---|---|---|---|
| 01 Dec 2026 | 05 Nov 2026 | 15 Dec 2026 | 0.05 现金 |
| 01 Sep 2026 | 20 Aug 2026 | 15 Sep 2026 | 0.05 现金 |
| 01 Jun 2026 | 27 Apr 2026 | 15 Jun 2026 | 0.05 现金 |
| 02 Mar 2026 | 29 Jan 2026 | 16 Mar 2026 | 0.045 现金 |
| 01 Dec 2025 | 31 Oct 2025 | 15 Dec 2025 | 0.045 现金 |
| 08 Sep 2025 | 26 Aug 2025 | 16 Sep 2025 | 0.045 现金 |
| 30 May 2025 | 29 Apr 2025 | 13 Jun 2025 | 0.045 现金 |
| 03 Mar 2025 | 03 Feb 2025 | 17 Mar 2025 | 0.04 现金 |
| 02 Dec 2024 | 25 Oct 2024 | 16 Dec 2024 | 0.04 现金 |
| 09 Sep 2024 | 26 Aug 2024 | 17 Sep 2024 | 0.04 现金 |
| 31 May 2024 | 22 Apr 2024 | 14 Jun 2024 | 0.04 现金 |
| 29 Feb 2024 | 25 Jan 2024 | 15 Mar 2024 | 0.035 现金 |
| 30 Nov 2023 | 06 Nov 2023 | 15 Dec 2023 | 0.035 现金 |
| 07 Sep 2023 | 23 Aug 2023 | 22 Sep 2023 | 0.435 现金 |
| 31 May 2023 | 27 Apr 2023 | 15 Jun 2023 | 0.035 现金 |
| 28 Feb 2023 | 26 Jan 2023 | 15 Mar 2023 | 0.03 现金 |
| 30 Nov 2022 | 28 Oct 2022 | 15 Dec 2022 | 0.03 现金 |
| 01 Sep 2022 | 18 Aug 2022 | 15 Sep 2022 | 0.03 现金 |
| 16 May 2022 | 28 Apr 2022 | 31 May 2022 | 0.03 现金 |
| 显示更多 | |||
每年股息收益率
| 年份 | 每年总股息 ($) | 频率/年份 | 收益率 % |
|---|---|---|---|
| 2026 | 0.195 | 4 | 3.99 |
| 2025 | 0.175 | 4 | 2.84 |
| 2024 | 0.155 | 4 | 0.88 |
| 2023 | 0.535 | 4 | 8.92 |
| 2022 | 0.090 | 3 | 2.42 |
技术形态 中期
AI 技术分析
投资组合